2025-08-29 05:01:08
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Bharat Parenterals Ltd posts higher consolidated PAT of Rs. 7.95 crore in Q2FY22
Posted On : 2021-11-04 16:04:33( TIMEZONE : IST )
Bharat Parenterals Ltd has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 62.92 crores during the period ended September 30, 2021 as compared to Rs. 62.60 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 7.95 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 7.73 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 13.88 for the period ended September 30, 2021 as compared to Rs. 13.49 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 62.92 crs | ₹62.60 crs |  0.51% |
| Net Profit | ₹7.95 crs | ₹7.73 crs | 2.85% |
| EPS | ₹13.88 | ₹13.49 | 2.89% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 62.92 crores during the period ended September 30, 2021 as compared to Rs.61.61 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.7.95 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.6.45 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.13.88 for the period ended September 30, 2021 as compared to Rs.11.26 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 62.92 crs | ₹61.61 crs | 2.13% |
| Net Profit | ₹7.95 crs | ₹6.45 crs | 23.26% |
| EPS | ₹13.88 | ₹11.26 | 23.27% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.125.52 crores during the 6 Months period ended September 30, 2021 as compared to Rs.119.02 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.15.68 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.13.09 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.27.37 for the 6 Months period ended September 30, 2021 as compared to Rs.22.85 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹125.52 crs | ₹119.02 crs | 5.46% |
| Net Profit | ₹15.68 crs | ₹13.09 crs | 19.79% |
| EPS | ₹27.37 | ₹22.85 | 19.78% |
Shares of Bharat Parenterals Ltd was last trading in BSE at Rs. 402.10 as compared to the previous close of Rs. 385.25. The total number of shares traded during the day was 11079 in over 189 trades.
The stock hit an intraday high of Rs. 404.50 and intraday low of 389.00. The net turnover during the day was Rs. 4444577.00.
